Institutional Ownership Innate Pharma Sa (IPHA)
This table provides information about the institutional ownership of Innate Pharma Sa (IPHA). We have compiled data on the 9 institutions that hold shares in the stock, with a total of 238,049 shares, which have been reported (via 13F filing form) to have a value of $435,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Optiver Holding B.V.
Amsterdam, P7 |
Nov 14, 2024 Q3 2024 |
86,788
shares
|
$153,614
0.01% of portfolio
|
Q3 2024
Reduced 0.65%
|
|
|
Exchange Traded Concepts, LLC
|
Oct 10, 2024 Q3 2024 |
77,350
shares
|
$136,909
0.0% of portfolio
|
Q3 2024
Reduced 10.31%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
43,524
shares
|
$77,037
0.0% of portfolio
|
Q2 2024
Reduced 1.36%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
21,267
shares
|
$37,642
0.0% of portfolio
|
Q3 2024
Reduced 9.61%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
8,408
shares
|
$14,882
0.0% of portfolio
|
Q3 2024
Added 2730.98%
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
307
shares
|
$543
0.0% of portfolio
|
Q3 2024
Reduced 25.49%
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 12, 2024 Q3 2024 |
205
shares
|
$362
0.0% of portfolio
|
Q2 2023
New holding
|
|
|
Steward Partners Investment Advisory, LLC
|
Nov 14, 2024 Q3 2024 |
200
shares
|
$354
0.0% of portfolio
|
Q4 2023
Reduced 60.0%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|